Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study ; volume:14 ; number:1 ; day:20 ; month:12 ; year:2024 ; pages:1-10 ; date:12.2024
Blood cancer journal ; 14, Heft 1 (20.12.2024), 1-10, 12.2024
- Creator
-
Jaberi-Douraki, Majid
Xu, Xuan
Dima, Danai
Ailawadhi, Sikander
Anwer, Faiz
Mazzoni, Sandra
Valent, Jason
Habib, Muhammad Hamza
Riviere, Jim E.
Raza, Shahzad
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41408-024-01206-4
- URN
-
urn:nbn:de:101:1-2503012121547.017637413123
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jaberi-Douraki, Majid
- Xu, Xuan
- Dima, Danai
- Ailawadhi, Sikander
- Anwer, Faiz
- Mazzoni, Sandra
- Valent, Jason
- Habib, Muhammad Hamza
- Riviere, Jim E.
- Raza, Shahzad
- SpringerLink (Online service)
Other Objects (12)
Biological determinants of health disparities in multiple myeloma
TRPA1 is a molecular candidate to mediate drug-related gastrointestinal adverse events
Drug-related crime
Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma
Adverse event reporting in adult intensive care units and the impact of a multifaceted intervention on drug-related adverse events
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
Adverse drug reactions and drug-related problems with supportive care medications among the oncological population
Magnitude of income-related disparities in adverse perinatal outcomes
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Racial disparities in multiple myeloma and access to stem cell transplantation
Pharmacovigilance in oncology
Rhabdomyolysis in drug-related deaths
Biological determinants of health disparities in multiple myeloma
TRPA1 is a molecular candidate to mediate drug-related gastrointestinal adverse events
Drug-related crime
Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma
Adverse event reporting in adult intensive care units and the impact of a multifaceted intervention on drug-related adverse events
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
Adverse drug reactions and drug-related problems with supportive care medications among the oncological population
Magnitude of income-related disparities in adverse perinatal outcomes
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Racial disparities in multiple myeloma and access to stem cell transplantation
Pharmacovigilance in oncology
Rhabdomyolysis in drug-related deaths
Biological determinants of health disparities in multiple myeloma
TRPA1 is a molecular candidate to mediate drug-related gastrointestinal adverse events
Drug-related crime
Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma
Adverse event reporting in adult intensive care units and the impact of a multifaceted intervention on drug-related adverse events
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
Adverse drug reactions and drug-related problems with supportive care medications among the oncological population
Magnitude of income-related disparities in adverse perinatal outcomes
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Racial disparities in multiple myeloma and access to stem cell transplantation
Pharmacovigilance in oncology